Markus Md Renschler Cyteir Therapeutics, Inc. (CYT) insider trading activity

Markus Md Renschler is President and CEO of Cyteir Therapeutics, Inc.. Currently has a direct ownership of 1.1 Million shares of CYT, which is worth approximately $3.32 Million. The most recent transaction as insider was on Mar 04, 2024, when has been sold 6,304 shares (Common Stock) at a price of $1.69 per share, resulting in proceeds of $10,653. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.1M

0% 3M change

1.98% 12M change

Total Value Held $3.32 Million

MARKUS MD RENSCHLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2024	BUY Exercise of conversion of derivative security	$10,653 $1.69 p/Share	6,304 Added 0.57%	1,103,661 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	$21,958 $1.45 p/Share	15,144 Added 1.36%	1,097,357 Common Stock
Nov 20 2023	BUY Exercise of conversion of derivative security	$12,818 $1.45 p/Share	8,840 Added 0.81%	1,082,213 Common Stock
Nov 20 2023	BUY Exercise of conversion of derivative security	$122,723 $1.45 p/Share	84,637 Added 7.31%	1,073,373 Common Stock
Jan 13 2023	BUY Grant, award, or other acquisition	$7,450 $1.49 p/Share	5,000 Added 0.51%	983,736 Common Stock
Dec 21 2022	BUY Exercise of conversion of derivative security	$153,195 $1.12 p/Share	136,782 Added 12.26%	978,736 Common Stock

MMR

Markus Md Renschler

President and CEO

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYT shares.

Notify only if

Value

Insider Trading

Get notified when an Cyteir Therapeutics, Inc. insider buys or sells CYT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cyteir Therapeutics, Inc.

Track Activities on CYT

Account